Physician profile
Amit Narula
NPI 1497958193
$183,187.04
in general payments reported to CMS, 2019-2025
53 companies · $39K in 2025
The $39K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $32K · 2021: $5,413 · 2022: $18K · 2023: $33K · 2024: $23K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Food and Beverage: $16K · Travel and Lodging: $1,156 · Education: $415 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,891.00 |
| Food and Beverage | $16,450.61 |
| Travel and Lodging | $1,155.74 |
| Education | $414.79 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $56,176.73 | 2019-2024 | Yupelri, Yupelri |
| Astrazeneca Pharmaceuticals LP | $51,890.21 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $26,507.70 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12,902.91 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Jazz Pharmaceuticals INC. | $11,899.17 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $4,604.08 | 2019-2021 | |
| Viatris Specialty LLC | $3,900.39 | 2025 | Yupelri |
| Mallinckrodt Enterprises LLC | $2,237.28 | 2019 | |
| Harmony Biosciences LLC | $1,919.47 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $1,665.31 | 2021-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $1,362.14 | 2019-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $1,207.19 | 2020-2025 | Acthar |
| Genzyme Corporation | $1,181.98 | 2021-2025 | |
| Insmed, INC. | $683.27 | 2019-2025 | Arikayce |
| Axsome Therapeutics, INC. | $621.77 | 2022-2025 | Sunosi |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $449.61 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $407.75 | 2021-2025 | Xembify, Prolastin-C Liquid |
| Avadel Cns Pharmaceuticals, LLC | $389.04 | 2023-2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $337.64 | 2020-2025 | Glassia, Cuvitru, Eohilia |
| Verona Pharma, INC. | $323.34 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $291.43 | 2020-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $247.59 | 2019-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $227.82 | 2019-2024 | Opsumit |
| Amgen INC. | $163.12 | 2021-2024 | Tezspire |
| Ani Pharmaceuticals, INC. | $146.60 | 2022-2023 | Purified Cortrophin Gel |
| Philips North America LLC | $146.46 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Idorsia Pharmaceuticals US INC | $135.62 | 2023 | Quviviq |
| Vifor Pharma, INC. | $100.35 | 2024-2025 | Zemaira |
| Paratek Pharmaceuticals, INC. | $97.79 | 2022-2024 | Nuzyra |
| Teva Pharmaceuticals USA, INC. | $97.79 | 2020-2021 | |
| Resmed Corp | $97.47 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $89.62 | 2021-2025 | Zerbaxa, Recarbrio, Keytruda |
| Fisher & Paykel Healthcare INC | $73.57 | 2019-2023 | Fisher & Paykel Healthcare |
| Sanofi-Aventis U.S. LLC | $72.06 | 2020-2023 | |
| Optinose US, INC. | $60.92 | 2022 | |
| Janssen Biotech, INC. | $57.88 | 2025 | Tremfya |
| Advanced Respiratory, INC | $54.11 | 2019-2021 | |
| Circassia INC. | $50.60 | 2019-2020 | |
| Watermark Medical, INC. | $46.50 | 2024 | |
| Biomerieux INC | $33.94 | 2021 | |
| Arbor Pharmaceuticals, INC. | $25.00 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.79 | 2019 | |
| Pulmonx Corporation | $23.49 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Lilly USA, LLC | $23.43 | 2025 | Zepbound |
| Gilead Sciences, INC. | $20.68 | 2021 | |
| Tactile Systems Technology INC | $18.98 | 2024 | Entre Plus, Flexitouch Plus |
| Alexion Pharmaceuticals, INC. | $18.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.56 | 2022 | |
| Eisai INC. | $16.53 | 2021 | |
| Pfizer INC. | $15.84 | 2021 | |
| Genentech USA, INC. | $14.68 | 2019 | |
| Horizon Therapeutics Plc | $11.70 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Narula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.